|
|
|
-
2024 Estimated Capital Gain Distributions
Certain First Trust First Trust Exchange-Traded Funds are expected to pay a long-term capital gain distribution in December. For a list of exchange-traded funds expected to pay a long-term capital gain distribution, please click here. Also, certain First Trust Exchange-Traded Funds are expected to pay short-term capital gain distributions in December. For a list of exchange-traded funds expected to pay a short-term capital gain distribution, please click here. Final determination of the source and tax status of all distributions paid in the current year are to be made after year-end and could differ from the expectations noted above.
Investment Objective/Strategy - The First Trust US Equity Opportunities ETF (the "Fund"), formerly First Trust US IPO Index Fund, seeks investment results that correspond generally to the price and yield (before the Fund's fees and expenses) of an equity index called the IPOX®-100 U.S. Index. The Fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks that comprise the Index.
There can be no assurance that the Fund's investment objectives will be achieved.
-
The IPOX®-100 U.S. Index is a modified value-weighted price index measuring the performance of the top 100 companies ranked quarterly by market capitalization in the IPOX® Global Composite Index.
-
The index utilizes a 10% capping on all constituents and includes the 100 largest, typically best performing and most liquid U.S. public offerings ("IPOs") in the IPOX® Global Composite Index.
-
Index constituents are selected based on quantitative initial screens. In general, eligible constituents are added on the sixth day of trading and remain eligible to be included in the Index for approximately four years.
-
The index is reconstituted and adjusted quarterly.
Potential Benefits of the First Trust US Equity Opportunities ETF
-
Systematic exposure to U.S. equity capital and private equity activity and the growth and innovativeness of the U.S. economy via a semi-passive indexing approach.
-
Based on well researched, totally disciplined and transparent index methodology. The IPOX®-100 U.S. Index has historically captured around 85% of total market capitalization created through U.S. IPO activity during the past four years. Tilt towards mid- and large-cap stocks.
-
Investment tool for buy-and-hold investors seeking timely and systematic IPO exposure as well as active market participants due to dynamic index properties.
Ticker | FPX |
Fund Type | Growth |
Investment Advisor | First Trust Advisors L.P. |
Investor Servicing Agent | Bank of New York Mellon Corp |
CUSIP | 336920103 |
ISIN | US3369201039 |
Intraday NAV | FPXIV |
Fiscal Year-End | 12/31 |
Exchange | NYSE Arca |
Inception | 4/12/2006 |
Inception Price | $20.00 |
Inception NAV | $20.00 |
Rebalance Frequency | Quarterly |
Total Expense Ratio* | 0.59% |
Net Expense Ratio* | 0.59% |
* As of 5/1/2024
Expenses are capped contractually at 0.60% per year, at least through April 30, 2025.
Closing NAV1 | $124.55 |
Closing Market Price2 | $124.44 |
Bid/Ask Midpoint | $124.60 |
Bid/Ask Premium | 0.04% |
30-Day Median Bid/Ask Spread3 | 0.09% |
Total Net Assets | $821,998,114 |
Outstanding Shares | 6,600,002 |
Daily Volume | 20,838 |
Average 30-Day Daily Volume | 14,489 |
Closing Market Price 52-Week High/Low | $125.80 / $86.50 |
Closing NAV 52-Week High/Low | $125.74 / $86.43 |
Number of Holdings (excluding cash) | 100 |
Holding |
Percent |
Samsara Inc. (Class A) |
6.80% |
Palantir Technologies Inc. (Class A) |
6.73% |
Carrier Global Corporation |
6.51% |
Applovin Corp. (Class A) |
6.31% |
DoorDash, Inc. (Class A) |
4.12% |
Regeneron Pharmaceuticals, Inc. |
4.12% |
GE Vernova Inc. |
3.65% |
Constellation Energy Corporation |
3.56% |
Kenvue Inc. |
3.09% |
Duolingo, Inc. |
2.51% |
* Excluding cash.
Holdings are subject to change.
Past performance is not indicative of future results.
Maximum Market Cap. | $93,072 |
Median Market Cap. | $6,924 |
Minimum Market Cap. | $2,010 |
Price/Earnings | 27.33 |
Price/Book | 5.36 |
Price/Cash Flow | 19.12 |
Price/Sales | 3.42 |
|
2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Days Traded at Premium |
144 |
39 |
40 |
38 |
Days Traded at Discount |
106 |
22 |
23 |
26 |
Information Technology
|
27.54%
|
Industrials
|
18.71%
|
Health Care
|
13.40%
|
Financials
|
13.32%
|
Consumer Discretionary
|
10.83%
|
Utilities
|
4.33%
|
Consumer Staples
|
3.72%
|
Communication Services
|
3.46%
|
Energy
|
2.95%
|
Materials
|
1.21%
|
Real Estate
|
0.53%
|
|
|
Tracking Index: IPOX® 100 U.S. Index
|
Standard Deviation |
Alpha |
Beta |
Sharpe Ratio |
Correlation |
FPX |
23.62% |
-11.83 |
1.18 |
-0.24 |
0.88 |
Russell 3000® Index |
17.48% |
--- |
1.00 |
0.31 |
1.00 |
Standard Deviation is a measure of price variability (risk). Alpha is an indication of how much an investment outperforms or underperforms
on a risk-adjusted basis relative to its benchmark.Beta is a measure of price variability relative to the market. Sharpe Ratio is a measure
of excess reward per unit of volatility. Correlation is a measure of the similarity of performance.
Russell 3000® Index - The Index is comprised of the 3000 largest and most liquid stocks based and traded in the U.S. S&P 500® Index - The Index is an unmanaged index of 500 companies used to measure large-cap U.S. stock market performance.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|